{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:40:38Z","timestamp":1760604038087,"version":"build-2065373602"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"RCSI \/ Bons Secours StAR MD"},{"DOI":"10.13039\/501100001593","name":"Irish Cancer Society","doi-asserted-by":"publisher","award":["CRF21SUL"],"award-info":[{"award-number":["CRF21SUL"]}],"id":[{"id":"10.13039\/501100001593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacogenomics J"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1038\/s41397-025-00384-z","type":"journal-article","created":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T07:51:35Z","timestamp":1759477895000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serine-arginine protein kinase 1 (SRPK1) is under-expressed in mucinous colorectal cancer, and may mediate resistance to oxaliplatin"],"prefix":"10.1038","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7430-9973","authenticated-orcid":false,"given":"William P.","family":"Duggan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammedreza","family":"Azimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyndsey","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graeme P.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian. S.","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Fay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heiko","family":"Dussmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tr\u00edona","family":"N\u00ed Chonghaile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katherine M.","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karin","family":"Jirstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3479-7794","authenticated-orcid":false,"given":"Jochen H. M.","family":"Prehn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P.","family":"Burke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,3]]},"reference":[{"key":"384_CR1","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1136\/gutjnl-2022-327736","volume":"72","author":"E Morgan","year":"2023","unstructured":"Morgan E, Arnold M, Gini A, Lorenzoni V, Cabasag CJ, Laversanne M, et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN. Gut. 2023;72:338\u201344.","journal-title":"Gut"},{"key":"384_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.6004\/jnccn.2021.0012","volume":"19","author":"AB Benson","year":"2021","unstructured":"Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK, et al. Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw. 2021;19:329\u201359.","journal-title":"J Natl Compr Cancer Netw"},{"key":"384_CR3","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.6004\/jnccn.2022.0051","volume":"20","author":"AB Benson","year":"2022","unstructured":"Benson AB, Venook AP, Al-Hawary MM, Azad N, Chen YJ, Ciombor KK, et al. Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw. 2022;20:1139\u201367.","journal-title":"J Natl Compr Cancer Netw"},{"key":"384_CR4","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1007\/s10350-004-0932-1","volume":"48","author":"H Kang","year":"2005","unstructured":"Kang H, O\u2019Connell JB, Maggard MA, Sack J, Ko CY. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum. Dis colon rectum. 2005;48:1161\u20138.","journal-title":"Dis colon rectum"},{"key":"384_CR5","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1002\/1097-0142(197604)37:4<1891::AID-CNCR2820370439>3.0.CO;2-Z","volume":"37","author":"DA Symonds","year":"1976","unstructured":"Symonds DA, Vickery AL. Mucinous carcinoma of the colon and rectum. Cancer. 1976;37:1891\u2013900.","journal-title":"Cancer"},{"key":"384_CR6","unstructured":"Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumours of the digestive system. WHO Classification of Tumours, 4th ed. Vol. 3; 2010."},{"key":"384_CR7","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1097\/DCR.0000000000000635","volume":"59","author":"N McCawley","year":"2016","unstructured":"McCawley N, Clancy C, O\u2019Neill BD, Deasy J, McNamara DA, Burke JP. Mucinous rectal adenocarcinoma is associated with a poor response to neoadjuvant chemoradiotherapy: a systematic review and meta-analysis. Dis colon rectum. 2016;59:1200\u20138.","journal-title":"Dis colon rectum"},{"key":"384_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/00015458.2013.11680951","volume":"113","author":"H Debunne","year":"2013","unstructured":"Debunne H, Ceelen W. Mucinous differentiation in colorectal cancer: molecular, histological and clinical aspects. Acta Chir Belg. 2013;113:385\u201390.","journal-title":"Acta Chir Belg"},{"key":"384_CR9","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.3390\/cancers14051297","volume":"14","author":"JW Bong","year":"2022","unstructured":"Bong JW, Gim JA, Ju Y, Cheong C, Lee SI, Oh SC, et al. Prognosis and sensitivity of adjuvant chemotherapy in mucinous colorectal adenocarcinoma without distant metastasis. Cancers. 2022;14:1297.","journal-title":"Cancers"},{"key":"384_CR10","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.3390\/cancers13061389","volume":"13","author":"E O\u2019Connell","year":"2021","unstructured":"O\u2019Connell E, Reynolds IS, McNamara DA, Burke JP, Prehn JHM. Resistance to cell death in mucinous colorectal cancer-a review. Cancers. 2021;13:1389.","journal-title":"Cancers"},{"key":"384_CR11","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1038\/s41397-021-00229-5","volume":"21","author":"E O\u2019Connell","year":"2021","unstructured":"O\u2019Connell E, Reynolds IS, Salvucci M, McNamara DA, Burke JP, Prehn JHM. Mucinous and non-mucinous colorectal cancers show differential expression of chemotherapy metabolism and resistance genes. pharmacogenomics J. 2021;21:510\u20139.","journal-title":"pharmacogenomics J"},{"key":"384_CR12","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41397-019-0137-6","volume":"20","author":"IS Reynolds","year":"2020","unstructured":"Reynolds IS, O\u2019Connell E, Fichtner M, McNamara DA, Kay EW, Prehn JHM, et al. Mucinous adenocarcinoma is a pharmacogenomically distinct subtype of colorectal cancer. pharmacogenomics J. 2020;20:524\u201332.","journal-title":"pharmacogenomics J"},{"key":"384_CR13","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1002\/jso.25764","volume":"120","author":"IS Reynolds","year":"2019","unstructured":"Reynolds IS, O\u2019Connell E, Fichtner M, McNamara DA, Kay EW, Prehn JHM, et al. Mucinous adenocarcinoma of the colon and rectum: a genomic analysis. J Surg Oncol. 2019;120:1427\u201335.","journal-title":"J Surg Oncol"},{"key":"384_CR14","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/j.1742-4658.2010.07987.x","volume":"278","author":"T Giannakouros","year":"2011","unstructured":"Giannakouros T, Nikolakaki E, Mylonis I, Georgatsou E. Serine-arginine protein kinases: a small protein kinase family with a large cellular presence. FEBS J. 2011;278:570\u201386.","journal-title":"FEBS J"},{"key":"384_CR15","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1007\/s11010-022-04456-7","volume":"477","author":"WP Duggan","year":"2022","unstructured":"Duggan WP, O\u2019Connell E, Prehn JHM, Burke JP. Serine-Arginine Protein Kinase 1 (SRPK1): a systematic review of its multimodal role in oncogenesis. Mol Cell Biochem. 2022;477:2451\u201367.","journal-title":"Mol Cell Biochem"},{"key":"384_CR16","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1593\/neo.03406","volume":"6","author":"PW Schenk","year":"2004","unstructured":"Schenk PW, Stoop H, Bokemeyer C, Mayer F, Stoter G, Oosterhuis JW, et al. Resistance to platinum-containing chemotherapy in testicular germ cell tumors is associated with downregulation of the protein kinase SRPK1. Neoplasia. 2004;6:297\u2013301.","journal-title":"Neoplasia"},{"key":"384_CR17","doi-asserted-by":"publisher","first-page":"727","DOI":"10.7150\/jca.7576","volume":"4","author":"Q Wu","year":"2013","unstructured":"Wu Q, Chang Y, Zhang L, Zhang Y, Tian T, Feng G, et al. SRPK1 dissimilarly impacts on the growth, metastasis, chemosensitivity and angiogenesis of glioma in normoxic and hypoxic conditions. J Cancer. 2013;4:727\u201335.","journal-title":"J Cancer"},{"key":"384_CR18","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/pbc.21088","volume":"50","author":"S Krishnakumar","year":"2008","unstructured":"Krishnakumar S, Mohan A, Kandalam M, Ramkumar HL, Venkatesan N, Das RR. SRPK1: a cisplatin sensitive protein expressed in retinoblastoma. Pediatr Blood Cancer. 2008;50:402\u20136.","journal-title":"Pediatr Blood Cancer"},{"key":"384_CR19","first-page":"6982","volume":"61","author":"PW Schenk","year":"2001","unstructured":"Schenk PW, Boersma AW, Brandsma JA, den Dulk H, Burger H, Stoter G, et al. SKY1 is involved in cisplatin-induced cell kill in saccharomyces cerevisiae, and inactivation of its human homologue, SRPK1, induces cisplatin resistance in a human ovarian carcinoma cell line. Cancer Res. 2001;61:6982\u20136.","journal-title":"Cancer Res"},{"key":"384_CR20","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical Association","year":"2013","unstructured":"World Medical Association. World medical association declaration of helsinki: ethical principles for medical research involving human subjects. Jama. 2013;310:2191\u20134.","journal-title":"Jama"},{"key":"384_CR21","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ccr.2007.05.008","volume":"12","author":"DA Guertin","year":"2007","unstructured":"Guertin DA, Sabatini DM. Defining the role of mTOR in cancer. Cancer Cell. 2007;12:9\u201322.","journal-title":"Cancer Cell"},{"key":"384_CR22","doi-asserted-by":"publisher","first-page":"2690","DOI":"10.3390\/biomedicines10112690","volume":"10","author":"SY Park","year":"2022","unstructured":"Park SY, Chung YS, Park SY, Kim SH. Role of AMPK in regulation of oxaliplatin-resistant human colorectal cancer. Biomedicines. 2022;10:2690.","journal-title":"Biomedicines"},{"key":"384_CR23","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1365-2796.1993.tb00647.x","volume":"233","author":"G Berglund","year":"1993","unstructured":"Berglund G, Elmst\u00e4hl S, Janzon L, Larsson SA. The malmo diet and cancer study. design and feasibility. J Intern Med. 1993;233:45\u201351.","journal-title":"J Intern Med"},{"key":"384_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1746-1596-8-10","volume":"8","author":"S Wangefjord","year":"2013","unstructured":"Wangefjord S, Br\u00e4ndstedt J, Lindquist KE, Nodin B, Jirstr\u00f6m K, Eberhard J. Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer. Diagn Pathol. 2013;8:10.","journal-title":"Diagn Pathol"},{"key":"384_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/2042-6410-4-17","volume":"4","author":"S Wangefjord","year":"2013","unstructured":"Wangefjord S, Sundstr\u00f6m M, Zendehrokh N, Lindquist KE, Nodin B, Jirstr\u00f6m K, et al. Sex differences in the prognostic significance of KRAS codons 12 and 13, and BRAF mutations in colorectal cancer: a cohort study. Biol Sex Differ. 2013;4:17.","journal-title":"Biol Sex Differ"},{"key":"384_CR26","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/nm0798-844","volume":"4","author":"J Kononen","year":"1998","unstructured":"Kononen J, Bubendorf L, Kallioniemi A, B\u00e4rlund M, Schraml P, Leighton S, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4:844\u20137.","journal-title":"Nat Med"},{"key":"384_CR27","doi-asserted-by":"publisher","first-page":"33","DOI":"10.13064\/KSSS.2018.10.1.033","volume":"10","author":"S Park","year":"2018","unstructured":"Park S, Jeong Y, Kim HS. Multi-resolution DenseNet based acoustic models for reverberant speech recognition. Phonetics Speech Sci. 2018;10:33\u20138.","journal-title":"Phonetics Speech Sci"},{"key":"384_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-021-02954-8","volume":"19","author":"J-Q Huang","year":"2021","unstructured":"Huang J-Q, Li H-F, Zhu J, Song J-W, Zhang X-B, Gong P, et al. SRPK1\/AKT axis promotes oxaliplatin-induced anti-apoptosis via NF-\u03baB activation in colon cancer. J Transl Med. 2021;19:280.","journal-title":"J Transl Med"},{"key":"384_CR29","doi-asserted-by":"publisher","first-page":"5359","DOI":"10.2147\/OTT.S172541","volume":"11","author":"N Yi","year":"2018","unstructured":"Yi N, Xiao M, Jiang F, Liu Z, Ni W, Lu C, et al. SRPK1 is a poor prognostic indicator and a novel potential therapeutic target for human colorectal cancer. OncoTargets Ther. 2018;11:5359\u201370.","journal-title":"OncoTargets Ther"},{"key":"384_CR30","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1016\/j.molcel.2014.03.007","volume":"54","author":"P Wang","year":"2014","unstructured":"Wang P, Zhou Z, Hu A, Ponte de Albuquerque C, Zhou Y, Hong L, et al. Both decreased and increased SRPK1 levels promote cancer by interfering with PHLPP-mediated dephosphorylation of Akt. Mol Cell. 2014;54:378\u201391.","journal-title":"Mol Cell"},{"key":"384_CR31","doi-asserted-by":"publisher","first-page":"e0169439","DOI":"10.1371\/journal.pone.0169439","volume":"12","author":"M Lu","year":"2017","unstructured":"Lu M, Zessin AS, Glover W, Hsu DS. Activation of the mTOR pathway by oxaliplatin in the treatment of colorectal cancer liver metastasis. PLoS one. 2017;12:e0169439.","journal-title":"PLoS one"},{"key":"384_CR32","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1158\/1078-0432.CCR-13-0027","volume":"19","author":"K Ng","year":"2013","unstructured":"Ng K, Tabernero J, Hwang J, Bajetta E, Sharma S, Del Prete SA, et al. Phase II study of everolimus in patients with metastatic colorectal adenocarcinoma previously treated with bevacizumab-, fluoropyrimidine-, oxaliplatin-, and irinotecan-based regimens. Clin cancer Res : an Off J Am Assoc Cancer Res. 2013;19:3987\u201395.","journal-title":"Clin cancer Res : an Off J Am Assoc Cancer Res"},{"key":"384_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-017-0164-3","volume":"15","author":"UA Bommer","year":"2017","unstructured":"Bommer UA, Vine KL, Puri P, Engel M, Belfiore L, Fildes K, et al. Translationally controlled tumour protein TCTP is induced early in human colorectal tumours and contributes to the resistance of HCT116 colon cancer cells to 5-FU and oxaliplatin. Cell Commun Signal. 2017;15:9.","journal-title":"Cell Commun Signal"},{"key":"384_CR34","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1007\/s10637-012-9793-y","volume":"30","author":"CE Atreya","year":"2012","unstructured":"Atreya CE, Ducker GS, Feldman ME, Bergsland EK, Warren RS, Shokat KM. Combination of ATP-competitive mammalian target of rapamycin inhibitors with standard chemotherapy for colorectal cancer. Investigational N drugs. 2012;30:2219\u201325.","journal-title":"Investigational N drugs"},{"key":"384_CR35","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41388-019-0999-8","volume":"39","author":"T-T Wei","year":"2020","unstructured":"Wei T-T, Lin Y-T, Tang S-P, Luo C-K, Tsai C-T, Shun C-T, et al. Metabolic targeting of HIF-1\u03b1 potentiates the therapeutic efficacy of oxaliplatin in colorectal cancer. Oncogene. 2020;39:414\u201327.","journal-title":"Oncogene"},{"key":"384_CR36","doi-asserted-by":"publisher","first-page":"2995","DOI":"10.1158\/1078-0432.CCR-12-1542","volume":"19","author":"M Selvakumaran","year":"2013","unstructured":"Selvakumaran M, Amaravadi RK, Vasilevskaya IA, O\u2019Dwyer PJ. Autophagy inhibition sensitizes colon cancer cells to antiangiogenic and cytotoxic therapy. Clin cancer Res : an Off J Am Assoc Cancer Res. 2013;19:2995\u20133007.","journal-title":"Clin cancer Res : an Off J Am Assoc Cancer Res"},{"key":"384_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-017-0675-y","volume":"16","author":"Q Xu","year":"2017","unstructured":"Xu Q, Liu X, Liu Z, Zhou Z, Wang Y, Tu J, et al. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K\/AKT pathway. Mol cancer. 2017;16:103.","journal-title":"Mol cancer"}],"container-title":["The Pharmacogenomics Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41397-025-00384-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41397-025-00384-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41397-025-00384-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T08:12:03Z","timestamp":1760602323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41397-025-00384-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["384"],"URL":"https:\/\/doi.org\/10.1038\/s41397-025-00384-z","relation":{},"ISSN":["1470-269X","1473-1150"],"issn-type":[{"type":"print","value":"1470-269X"},{"type":"electronic","value":"1473-1150"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"27 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no competing interests to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was conducted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Ethical approval was granted by the Beaumont Hospital Research and Ethics Committee under approval 08\/62 (Reference 21\/98) and written informed consent was obtained from all participants prior to their inclusion in the study. The study was also approved of by the Ethics committee of Lund University (Reference 51\/90, 445\/07 and 530\/08) and written informed consent was obtained from all participants prior to their inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors have granted permission for publication of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"26"}}